Synthace Partners With Charles River To Improve Assays

Synthace announced a collaboration with Charles River Laboratories to offer clients access to Synthace's assay-development software, following a proof-of-concept that developed a 1536-well assay and implemented over 700 experimental conditions across multiple laboratories. The integration combines design-of-experiments (DoE), automation and software to improve reproducibility amid a cited 72% researcher concern and an estimated $100 billion annual preclinical cost. The collaboration aims to speed assay development and enable more robust assay transfer between sites.